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ORIGINAL RESEARCH REPORTS
ChEmothEraPY
Arsenic trioxide plus cisplatin/ interferon α-
2b/ doxorubicin/ capecitabine combination 
chemotherapy for unresectable hepatocellular 
carcinoma
Tomuleasa and colleagues from Romania showed in vitro that the 
addition of arsenic trioxide to conventional chemotherapy sensit
tized liver stemtlike cancer cells, which show increased resistance to 
cancer drugs, to conventional chemotherapy. Further studies in anit
mal models are needed before the approach is tested in humans.
infECtions
Cytomegalovirus infections in unrelated cord blood 
transplantation in pediatric patients: incidence, risk 
factors, and outcomes
In a retrospective casetcontrol study, AltHajjar and colleagues 
of King Faisal Specialist Hospital, Riyadh, Saudi Arabia, found 
that 68% of 73 pediatric patients were CMV seropositive aft
ter UCBT for HSCT. High levels of CMV antigenemia were 
associated with a higher risk of progression to CMV disease. 
CMV infections was associated with CMV seropositivity, 
GVHD, use of hightdose corticosteroids, underlying diseast
es and older age at time of transplant. The authors conclude 
that CMV infection is a significant complication in pediatric 
patients who are UCBT recipients and is associated with an 
increase in transplanttrelated morbidity and mortality. Late 
CMV infection was strongly associated with a previous history 
of CMV infection.
rEnaL transPLantation
Very late onset lymphoproliferative disorders 
occurring over 10 years post-renal transplantation: 
PTLD.Int. Survey
Taheri and Khemat from Tehran, Iran, in a search of the medical 
literature, found 27 reports with 303 patients with lymphoprot
liferative disorders after renal transplantation. Patients with very 
late onset PTLD were less likely to be under MMF and/or FKt
506 (vs azathioprine)tbased immunosuppression and less likely 
to have a history of antibody induction immunosuppression. 
Older patients were at a greater risk of very late onset PTLD. 
Survival analysis showed no difference in outcome.
CASE REPORTS
Rosai-Dorfman disease of the paranasal sinuses 
and orbit
Khan and colleagues from Sir Ganga Ram Hospital in New 
Delhi present an unusual case in a 30tyeartold woman of Rosai 
Dorfman disease with extranodal involvement, affecting the nose, 
paranasal sinuses, and right orbit, but without any accompanying 
lymphadenopathy.
Complete recovery following sudden sensorineural 
hearing loss in a patient with sickle cell disease
A case presented by Alkindi and colleagues of Sultan Qaboos 
University Hospital in Oman demonstrates the otologic manit
festations of sickle cell disease. The 26tyeartold female responded 
well to steroids, which averted a permanent hearing loss.
Successful treatment of steroid-refractory 
autoimmune thrombocytopenia associated with 
Castleman disease with anti-CD-20 antibody 
(rituximab)
Ibrahim and colleagues of King Faisal Specialist Hospital in 
Riyadh successfully treated a  70tyeartold female with multicent
tric Castleman disease with rituximab after failed steroid treatt
ment and a transient response to intravenous immunoglobulin. 
There was complete recovery of her platelet count and very good 
response in nodal disease after 3 weekly doses.
